Australia fast bowler Megan Schutt has been handed a two-match suspension by Cricket Australia after failing to strictly adhere to regulatory guidelines regarding the use of personal prescription medication during an out-of-competition period.
The 33-year-old veteran seamer has accepted the penalty, which stems from a single, isolated incident that took place before the Australian team’s home series against Bangladesh. The suspension applies across all formats and will rule Schutt out of two immediate fixtures: the upcoming third T20 international against New Zealand and the opening match of the Women’s Big Bash League season for the Adelaide Strikers against the Melbourne Stars on Saturday, October 31.
Cricket Australia formally announced the disciplinary action on Thursday through an official statement detailing the nature of the breach. The governing body clarified that the medication in question was entirely non-performance-enhancing and that the infraction involved administrative protocols rather than any attempt to gain a competitive advantage.
"The breach was a failure to adhere to requirements under the Sports Science and Sports Medicine guidelines with regard to prescription medication," the Cricket Australia statement read. "This relates to a single incidence which occurred while out of competition and was not for performance enhancing purposes. The two-match ban includes all international and domestic cricket. We will continue to provide appropriate support to Megan and reinforce the standards and responsibilities expected of everyone representing our game."
Under the established regulations of Cricket Australia and relevant anti-doping authorities, the use of personal prescription medication that lacks performance-enhancing qualities is entirely legal. However, the governing bodies maintain rigorous and strict guidelines dictating that such prescriptions must be strictly for personal use and declared or managed in accordance with specific sports science and medical protocols.
Schutt acknowledged her responsibility in a public statement released shortly after the governing body’s announcement, confirming that she would not contest the penalty and expressing remorse for the situation.
"I fully accept the penalty handed down and apologise for failing to meet the standards expected of me," Schutt said. "I’m sorry for the attention this has caused and appreciate the support I’ve received. While this occurred out of competition and was not performance related, I understand that I am responsible for following the Sports Science and Sports Medicine Guidelines, which players receive regular education on and I should have adhered to these guidelines."
The investigation into the incident had been ongoing while Schutt continued to represent her state and country. During the period while the matter was being reviewed, the experienced seamer remained available for selection and participated in four matches. Her domestic and international fixtures during the investigation included an appearance for South Australia in the Women’s National Cricket League, where she claimed figures of 2 for 49. She followed that performance with a strong showing in the three-match ODI series against Bangladesh, picking up figures of 2 for 19, 4 for 36, and 4 for 16.
Schutt was also part of the Australian squad for the opening matches of the T20 international series against New Zealand on Sunday and Tuesday, though she was not selected in the playing XI for those fixtures.
With the investigation now formally concluded and the penalty accepted, Schutt will serve the two-match suspension across the team’s upcoming encounters. The first leg of her ban will be served during Thursday’s third T20I against New Zealand, with the second half keeping her sidelined for the Adelaide Strikers’ opening fixture of the upcoming WBBL campaign at the end of the month. Cricket Australia has reiterated its commitment to supporting the player through the transition back to regular availability while emphasizing the mandatory nature of medical compliance for all representatives of the national program.
Comments (0)